Abstract  by unknown
268A JACC February 1997
w
ABSTRACTS – Poster
L-Arginine Reduces the Incressed Incidence of
Ventricuier Arrhythmias During Sympathetic
Stimulation in Dogs with Acute Coronary Artery
Occlusion
L. Fei, C. Amett, D.P.Zipes. Krarrrreti Institute of Cardiology, Indiana
UniversityMedical Centac Indianapolis, IN, USA
Nitric oxide (NO) modulates autonomic effects on mechanical and electro-
phyaiologic funclion of the heart. Whether NO influences the prevalence of
ventricular arrhylhmiaa (VA) enhanced by sympathetic stimulation (SS) is
unknown. We studied the influence of the NO precursor, L-arginine (LA), on
the incidence of spontaneous VA during SS in 15 autonomically denawated
dogs undergoing repeated 7 min occlusions of the left descending coronary
artery. Bilateral SS (4 Hz, 4 ms, 4-15 volts) was delivered to decentralized
stellate ganglia. The effects of LA (100 mM) were assessed by infusing the
drug into the pericardial aac for 30 min where it superfused cardiac vagal
and sympathetic newes. The study protocol and results are shown in the
figure. Seven dogs were eliminated because they had no VA during SS.
The incidence of VA significantly increased during SS, while LA reduced this
increase caused by SS. After washout of LA, the incidence of VA increased
to the aame degree as before pericardial superfusion with LA (p = 0.600).
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Conclusions: Intrapericardial LA reducea the increased incidence of ven-
tricular arrhythmias during SS in dogs with acute corona~ occlusion, which
may relate to IA-related modulation of sympathetic activity.
1988-1001 ACorOnarySelective ATP-sensitive Potassium
Channels Opener, JTV-506, Improves Myocerdial
ischemia without Alteration of Systemic
Hemodynamics in the Cenine Heafts
H. Funaya, M. Kitakeze, H. Sate, M. Hon. The First Dept. of Med., Oszdca
Uniw, Osaka, Japan
ATP-sensitive K+ channels opener (KCO) mediates cardioprotective effects.
However, an intravenous administration of KCO may acutely reduce aorfic
blood pressure, which blunts the cardioproteefion of KCO activating sympa-
thetic tonas and renin-angiotensin systems. Since experiments using coro-
nary vascular rings revealed that JTV-506, a new KCO, is coronary-selective,
we tested if intravenous administration of JTV-506 mediates eerdioprotec-
tion on ischemic hearts without alteration of systemic hemodynamics. In 20
dogs, tha left anterior descending coronary artery (LAD) was perfused with
bloodfrom the carotidartery.When we administered JTV-506 (1, 2, 4, 6
and 8 w @kg) into the systemic vein, coronary blood flow (CBF) increased
dose-dependently from 92 + 1 to 110+5 ml/100 g/rein without reduction of
aortic blood pressure (AoP: 107 + 2 and 102 + 4 mmHg). When doses of
JTW508 increased to 16Lt g/kg, CBFdecreased to 101& 3 ml/100 g/reinwith
decreased AoP (87 + 5 mmHg). In the ischemic heart due to the constant
reduction of coronary perfusion preasure (CPP: 52 + 5 mmHg), CBF (53 +
1 ml/100 g/rein), fractional shortening (FS: 12 + 1%) and lactate extraction
ratio (LER: 0.3+ 2.1%) decreased. JTV-506 of 4 @kg increased CBF from
53+ 1 to 74 + 4 ml/100 ~min, while CPP and AoP were unchanged (58 + 3
and 101 + 3 mmHg). EntVEpi flow ratio increased from 0.73 + 0.05 to 0.64
+ 0.04, and FS (17 + 2Yo), LER (16 + 3%) and the pH in coronary venous
blood (7.16 * 0.05 to 7.36 l 0.02) were also increased. Norepinephrine,
renin activity and angiotenein II concentration in the systemic venous bloat
was not increased due to 8 #g/kg JTV-506 (389+ 146 vs. 182+65 pmol/ml,
11.1 + 1.7 vs. 11.8 + 1.3 ng/ml/min, 653 + 176 vs. 565 + 53 p@ml).
We ccmcludethat JTV-506 can mediate the selective corona~ vasodilation
and improvements of myoeerdial ischemia without affecting systemic blood
pressure, sympathetictonesandrenin-angiotensin systems. This ceronaty se-
lective new ATP-sensitive K+ channel openers, JT-506, may be promising
for the treatment of ischemic heart disease.
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Complement in Human Hearts during Acute
Myocardial Infarction
W.K. Lagrand1, H.W.M, Niesaen2, G.-J. Wolbink4, L.H. Jaspars2,
C.A. Visser’, F.W.A.Verheugt1, C.J.L.M. Meijer2, C.E. Hack3,4.
vDepa~mentof Card/o/og~ 2Department of Patholog~ 3Depatiment of
Internal Medicine, Free University Hoapital, Amsterdam, The Netherlands,
4 Cantral Laboratory of the Netherlands Red Cross Blood Transfusion
Service, Amsterdam, The Netherlands
C-reactive protein (CRP) plasma levels correlate with clinical outcome in pa-
tients with myocardiai ischemia and infarction, We hypothesized that these
correlations might reflect active participation of CRP in the local inflamma-
tory response ensuing in the jeopardized myocardium, since upon binding
to a Iigand CRP is able to activate the classical pathway of complement. In
addition, complement activation has been shown to occur ioeally in human
infarcted myocardium. To verify our hypothesis, we investigated immuno-
histochemical localization of CRP, in relation to deposition of complement,
in tissue specimens of infarcted and normal heart tissues obtained from 17
patients, who had died following acute myoeerdial infarction (AMI). CRP wee
found to be deposited only in infarcted ragions and not in normal appearing
areas of human myocardium, being co-localized with depositions of C4- and
C3-activation fragments of the complement system. Deposition of CRP and
complement in infarcted myoeardium appeared to be time-dependent since it
was found in all infarctions except for one of very short duration (<12 houra)
and two of long duration (>1 year).
Conclusion: CRP may localize in infarcted human heart tissue. As CRP
was found co-localized with complement, we auggest that this acute phase
protein promotes local complement activation, and hence tissue damage in
AMI.
m Early Refractorinessof platelet Gpll~iliain
Myocardial Infarction Survivors
P.J.Goldschmidt-Clermont, L.D. Coleman, P.F.Bray, R.S. Blumenthal.
Johns Hopkins University Baltimore, MD, USA
Aggregation of platelets is mediated by the binding of fibrinogen to the ac-
tivated conformation of integnn cAlb-f13(GPllb-llla) on the platelet surface.
With time after exposure of normal platelets to a stimulus (TRAP, 50 wM),
platelets lose the capacity to bind fibrinogen (left panel). Ofhers have ahown
that this refractoriness of GPllb-llle is due to internalization of the recep-
tor and is associated with loss of platelet aggregability. Platelet aggregation
within a coronary vessel corresponds to the triggering step in the devel-
opment of myoeardial infarction (Ml). We hypothesized that in suwivors of
myocardial infarction, GPllb+lla refractoriness might occur. To test this hy-
pothesis, we analyzed the platelets of 51 post-Ml patients, 3 to 21 days after
their events. Binding of fibrinogen to activated platelets ex vivo (1 #M ADP)
was significantly reduced in patients studied 3 to 5 days compared to 10 to
21 days post-Ml (p= 0.003), and in patients studiad 6 to 9 days varsus 10 to
21 days post-Ml (p= 0.01) (right panel).
Fibrinogen Binding to Platelets
120 woo
100 %-rj250M
> ,0 ~
3
& 24M0
*M ri,m
% ~
t#4a ~ lmo
8
%
s~
0 0
Time (mIn) Days Post-MI
Based on these data, it is tempting to speculate that platelets from Ml-
survivors undergo a period of refractoriness that might play an important
role in limiting the thrombotic process affecting the corona~ vessels of these
patients.
